(Press-News.org) A recent multicenter clinical trial of atorvastatin, a type of cholesterol-lowering drug, found that although the drug did not inhibit plasma HIV RNA levels, it did inhibit expression of cellular markers of immune activation and inflammation in patients with HIV infection. Since immune activation and inflammation are associated with progression of HIV infection, the implication is that the statin may inhibit disease progression and help in the infection's management. The findings are in a study, available online, published in The Journal of Infectious Diseases.
The investigators, led by Anuradha Ganesan, MD, of the National Naval Medical Center and the Infectious Disease Clinical Research Program in the Department of Preventive Medicine and Biometrics at the Uniformed Services University of the Health Sciences in Bethesda, Md., randomized 22 HIV-1-infected patients not on antiretroviral therapy and with cholesterol levels lower than those requiring statin therapy in a double-blind protocol of high-dose drug or placebo for eight weeks. After a four-to-six-week washout phase, each group was switched to the other treatment for another eight weeks.
The primary objective was to study the effect of atorvastatin on plasma HIV-1 RNA levels, as previous studies had shown conflicting results. The effect on cellular markers of immune activation was a secondary objective. HIV-1 RNA levels were not significantly affected by the drug, but levels of such immune activation markers as CD38 and HLA-DR on CD4 and CD8 T cells were reduced.
The researchers noted that their findings with atorvastatin suggest that understanding the mechanism by which statins affect immune markers may identify new approaches for the management of HIV infection. They point out, however, that their trial was not designed to demonstrate clinical benefits, for which larger studies of longer duration are needed.
In an accompanying editorial, Andrew Carr, MD, of St. Vincent's Hospital in Sydney, Australia, agreed, noting that "a very large study would probably be required to determine whether potentially positive effects of statin therapy on inflammatory biomarkers will translate into less HIV disease progression."
###
Fast Facts:
Statins show potential to alter the chronic immune activation observed in HIV-1 infected patients.
In the study, investigators randomized 22 HIV-1-infected patients not on antiretroviral therapy and with cholesterol levels lower than those requiring statin therapy in a double-blind protocol of high-dose atorvastatin or placebo for eight weeks. After a four-to-six-week washout phase, each group was switched to the other treatment for another eight weeks.
HIV-1 RNA levels were not significantly affected by the drug, but levels of such immune activation markers as CD38 and HLA-DR on CD4 and CD8 T cells were reduced.
The study and the accompanying editorial are available online:
"High Dose Atorvastatin Decreases Cellular Markers of Immune Activation without Affecting HIV-1 RNA Levels: Results of a Double-Blind Randomized Placebo Controlled Clinical Trial"
http://jid.oxfordjournals.org/content/early/2011/01/31/infdis.jiq115.full
"Statins as Anti-inflammatory Therapy in HIV disease?"
http://jid.oxfordjournals.org/content/early/2011/01/25/infdis.jiq120.full
Founded in 1904, The Journal of Infectious Diseases is the premier publication in the Western Hemisphere for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms. Articles in JID include research results from microbiology, immunology, epidemiology, and related disciplines. JID is published under the auspices of the Infectious Diseases Society of America (IDSA). Based in Arlington, Va., IDSA is a professional society representing more than 9,000 physicians and scientists who specialize in infectious diseases. For more information, visit www.idsociety.org.
Trial suggests statin may affect markers associated with progression of HIV
2011-02-17
ELSE PRESS RELEASES FROM THIS DATE:
New test shows promise for accurate diagnosis of Turner syndrome
2011-02-17
As a child grows, a short stature is not usually cause for concern, but it is often the only sign of a condition called Turner syndrome. Prevalent in girls, Turner syndrome is a genetic defect that short-circuits normal growth and leads to cardiac and renal problems. It is not commonly detected until age 10 or older when a youngster's unusually short height raises suspicions.
This lag before diagnosis of the condition can delay the start of growth hormone therapy, which can help in achieving normal or near-normal adult stature. Yale School of Medicine researchers are ...
Drug therapy shows significant benefit in treating a leading cause of childhood blindness
2011-02-17
A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity.
The results of a multicenter clinical trial led by researchers at The University of Texas Health Science Center at Houston (UTHealth) are published in the Feb. 17 issue of The New England Journal of Medicine.
Retinopathy of prematurity is a leading cause of childhood blindness worldwide. In the immature retina of babies born before 30 weeks' gestational age, the disease results ...
Research improves diagnosis and treatment of bleeding disorder
2011-02-17
A rare bleeding disorder that can lead to life-threatening bleeding episodes is misdiagnosed in 15 per cent of cases according to findings from a new international research project led by a Queen's professor.
"Correct diagnosis is critical because it determines the treatment decision," says Maha Othman, a professor in the Department of Anatomy and Cell Biology who led the three-year research project on the rare platelet type of von Willebrand disease (VWD).
Patients with VWD are commonly treated with drugs that help control their condition. However, these drugs aggravate ...
Global warming may reroute evolution
2011-02-17
ANN ARBOR, Mich.---Rising carbon dioxide levels associated with global warming may affect interactions between plants and the insects that eat them, altering the course of plant evolution, research at the University of Michigan suggests.
The research focused on the effects of elevated carbon dioxide on common milkweed, Asclepias syriaca. Milkweed is one of many plants that produce toxic or bitter chemical compounds to protect themselves from being eaten by insects. These chemical defenses are the result of a long history of interactions between the plants and insects ...
Children of working moms face more health problems
2011-02-17
Children of working mothers are significantly more likely to experience health problems, including asthma and accidents, than children of mothers who don't work, according to new research from North Carolina State University.
"I don't think anyone should make sweeping value judgments based on a mother's decision to work or not work," says Dr. Melinda Morrill, research assistant professor of economics at NC State and author of the study. "But, it is important that we are aware of the costs and benefits associated with a mother's decision to work."
The study looked at ...
Conservation of whitebark pine may hinge on preservation of ponderosa
2011-02-17
The caching of whitebark pine seeds by the Clark's nutcracker in late summer and early fall may not be enough to regenerate populations of the imperiled conifer in most of its range, scientists have found.
Their research—which is featured in the February issue of Science Findings, a monthly publication of the U.S. Forest Service's Pacific Northwest Research Station—suggests, for the first time, that the success of whitebark pine restoration may be linked to the conservation of another tree species: ponderosa pine.
"Whitebark pine is a keystone species in the high-mountain ...
2 knee replacements may be better than 1
2011-02-17
Replacing both knees in one surgery, or simultaneous total knee replacement (TKR) was associated with significantly fewer prosthetic joint infections as well as other revision knee operations within one year after surgery, compared with total knee replacements performed in two separate procedures. However, simultaneous replacement was associated with a moderately higher risk of adverse cardiovascular outcomes within 30 days, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
This study included 11,445 ...
Broader psychological impact of 2010 BP oil spill
2011-02-17
Baltimore, MD – Feb. 17, 2011. The explosion and fire on a BP-licensed oil platform in the Gulf of Mexico in April 2010 had huge environmental and economic effects, with millions of gallons of oil leaking into the water for more than five months. It also had significant psychological impact on people living in coastal communities, even in those areas that did not have direct oil exposure, according to researchers at the University of Maryland School of Medicine who worked in collaboration with the University of Florida, Gainesville. Study results will be published in the ...
Total knee replacement patients functioning well after 20 years
2011-02-17
Most patients who undergo total knee replacement (TKR) are age 60 to 80. More than 90 percent of these individuals experience a dramatic reduction in knee pain and a significant improvement in the ability to perform common activities. However questions have been raised about the decline in physical function over the long term despite the absence of implant-related problems. New research revealed today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) evaluates patient functionality 20 years after knee replacement.
"It is a common concern ...
Healthy lifestyle, positive attitude can help improve patient outcomes
2011-02-17
Joint replacement patients who improve their lifestyle and maintain a positive mindset prior to surgery are more likely to have better functional outcomes than those who do not, according to research presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). Multiple studies found that patients who smoke, misuse alcohol, fail to control blood sugar levels or simply have a poor attitude prior to undergoing total hip or knee replacement (THR/TKR) surgery can, in some cases, double their odds of post-operative complications.
Data were ...